Ever Supreme Bio Technology Co., Ltd. 6712

TPEX · Taiwan · Health Technology

TWD 161.00-1.00 (-0.62%)

Market open· Oct 2, 2026, 4:48 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Ever Supreme Bio Technology Co., Ltd. 6712

TPEX · Taiwan · Health Technology

TWD 161.00-1.00 (-0.62%)

Market open· Oct 2, 2026, 4:48 AM UTC· TWD · Data may be delayed

Company news

Yahoo FinanceJun 29, 2026

Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion

Ever Supreme Bio Technology Co., Ltd. (TWSE: 6712) announced on June 28 that CAR001, its proprietarily developed, allogeneic, "off-the-shelf" CAR-T cell therapy for cancer, has successfully cleared review by the Safety Monitoring Committee (SMC). Following a thorough evaluation of the Phase I safety profile and preliminary efficacy data, the committee has greenlit the advancement to the Phase IIa clinical trial. This milestone marks the successful completion of the critical safety assessment dur

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.